NDude Labs, a healthcare and wellness investment firm with operations in India and the United States, announced on October 6, 2026, that it has led a US$3 million Series A funding round in SuperMush, a U.S.-based functional wellness brand. Founded in 2022 by Alli Schaper and Brian Friedman, the company creates next-generation wellness products using research-backed ingredients such as nootropics, adaptogens, and functional mushrooms. The investment signals growing momentum for science-led brands in the rapidly expanding functional supplement market.
Company Background and Product Focus
SuperMush has built a product portfolio around clinically studied ingredients at meaningful doses, with recent launches including Shilajit, Creatine, and Lion's Mane gummies. The company serves a loyal customer community through a growing omnichannel presence that spans retail, direct-to-consumer, and marketplace channels. Its wellness-first mission focuses on bringing the power of functional mushrooms to a broader audience while maintaining a science-led approach to product development and quality.
Funding Purpose and Strategic Priorities
The new capital will support SuperMush as it expands its product portfolio, invests in high-efficacy formulations, and strengthens the team and customer support infrastructure required to reach more customers. The company also plans to deepen its presence across retail, direct-to-consumer, and marketplace channels in the United States. This investment is intended to accelerate growth while preserving the brand's wellness-first mission and its commitment to delivering measurable results.
Retail Expansion and Omnichannel Growth
Over the past year, SuperMush has expanded to more than 1,000 Target stores and now maintains a retail footprint exceeding 2,000 locations across the United States, including Target and Sprouts. The brand also sells through its own website and Amazon, creating a diversified omnichannel sales network that supports continued growth. This retail momentum reflects strong consumer demand for functional wellness products in mainstream grocery, wellness, and e-commerce channels.
Investor Perspective
NDude Labs invests in differentiated, science-backed products and founders with the vision to build enduring brands, according to Vikram Sehgal, Chief Operating Officer of NDude Labs. The firm's investment provides SuperMush with capital, talent, systems, and support to scale the business thoughtfully and sustainably. The transaction follows NDude Labs' recent investment in nutraceutical ingredients company Nutriventia, reflecting its continued focus on research-backed, ingredient-focused health and wellness businesses across India and the United States.
Founder Vision and Brand Ambition
Alli Schaper, Co-founder and Chief Executive Officer of SuperMush, described the partnership with NDude Labs as an exciting next phase after building a strong community, product range, and brand presence. Co-founder Brian Friedman added that the company aims to evolve SuperMush into the top premium functional supplement brand for active lifestyles. The founders intend to use clinically studied ingredients at meaningful doses to help consumers think better, move better, and feel their best.
Market Outlook and Category Leadership
SuperMush intends to set the standard for efficacy among functional wellness brands by building its portfolio around ingredients supported by rigorous science. This approach targets a consumer base that increasingly demands measurable results rather than marketing claims alone. The company will press its omnichannel advantage across retail, direct-to-consumer, and marketplace channels to establish itself as a category leader with the scale to match its ambition.
The Series A round positions SuperMush to accelerate product innovation and retail expansion while reinforcing NDude Labs' commitment to science-led wellness companies. With new capital and strategic support, SuperMush can scale operations, deepen customer engagement, and strengthen its market presence across multiple sales channels. The partnership highlights growing investor confidence in functional wellness brands that combine research-backed formulations with strong omnichannel distribution and a clear growth strategy.